Emerson (EMR) was downgraded by Oppenheimer (OPY) to outperform from perform with a price target of $53 due to a lack of catalysts to drive the price higher in the near termShares are lower by nearly nine tenths of a percent. Cliffs Natural (CLF) was downgraded by Goldman Sachs (GS) to sell with a price target of $25 due to higher costs and a potential production target miss.
